TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 19 | 21 | +2 |
| Shares | 350.9K | 643.6K | +292.7K (+83.4%) |
| Value | $2.12M | $1.07M | −$1.06M (−49.7%) |
New holders (4)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 185,695 | $308.3K | 0.01% |
| Nwam LLC | 10,240 | $17.0K | 0.00% |
| ORG Partners LLC | 740 | $1.32K | 0.00% |
| Raleigh Capital Management Inc. | 91 | $151 | 0.00% |
Sold out (2)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Newbridge Financial Services Group, Inc. | 434 | $2.62K |
| JPMorgan Chase & Co | 5 | $31 |